Screening for disease: making evidence-based choices.

Area of Science:

• Medical Screening
• Evidence-Based Medicine
• Clinical Trial Evaluation

Background:

• Screening tests are valuable only if they demonstrably reduce mortality or morbidity.
• Healthcare professionals need to critically assess screening research to ensure test efficacy.
• Potential harms include anxiety from false positives and delayed treatment from false negatives.

Purpose of the Study:

• To outline criteria for evaluating the utility and validity of illness screening tests.
• To discuss characteristics of diseases suitable for screening and requirements for effective screening tests.
• To identify and explain biases that can compromise screening trial results.

Main Methods:

• Review of principles for evidence-based screening test evaluation.
• Discussion of disease characteristics amenable to screening.
• Explanation of key test performance metrics (sensitivity, specificity, predictive value) and biases (screening, length, lead-time).

Main Results:

• Useful screening requires a significant health impact, an identifiable asymptomatic phase, and improved outcomes with early intervention.
• Effective screening tests need high sensitivity and specificity, cost-effectiveness, and patient acceptability.
• Potential biases like screening, length, and lead-time bias can distort outcomes and must be recognized.

Conclusions:

• The primary goal of illness screening must be to provide a demonstrable benefit, not merely to perform a test.
• Critical evaluation of screening research is essential for healthcare professionals to ensure tests are useful and safe.
• Understanding test characteristics and potential biases is crucial for accurate interpretation of screening trial results.